Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Johannes J. Sidelmann"'
Autor:
Ramshanker Ramanathan, Niels Peter R. Sand, Johannes J. Sidelmann, Bjarne L. Nørgaard, Jørgen B. Gram
Publikováno v:
Biology of Sex Differences, Vol 9, Iss 1, Pp 1-7 (2018)
Abstract Background Incidence and prevalence of cardiovascular disease (CVD) differ between sexes, and women experience CVD later than men. Changes in fibrin clot lysability are associated with CVD, and the present study addresses sex differences in
Externí odkaz:
https://doaj.org/article/344ed558615147aab5ed366f7891bbbe
Autor:
Jackie Trink, Renzhong Li, Yaseelan Palarasah, Stéphan Troyanov, Thomas E. Andersen, Johannes J. Sidelmann, Mark D. Inman, Salvatore V. Pizzo, Bo Gao, Joan C. Krepinsky
Publikováno v:
Biomedicines, Vol 9, Iss 9, p 1112 (2021)
Diabetic kidney disease (DKD) is caused by the overproduction of extracellular matrix proteins (ECM) by glomerular mesangial cells (MCs). We previously showed that high glucose (HG) induces cell surface translocation of GRP78 (csGRP78), mediating PI3
Externí odkaz:
https://doaj.org/article/a4a52abce55648158b7ad8d3e885382e
Autor:
Dorte, Glintborg, Johannes J, Sidelmann, Magda Lambaa, Altinok, Hanne, Mumm, Marianne, Andersen
Publikováno v:
Metabolism: clinical and experimental. 64(10)
Polycystic ovary syndrome (PCOS) is associated with risk factors for cardiovascular disease (CVD) which may be modified by the use of metformin and oral contraceptives (OC). Thrombin generation (TG) measures are risk markers of CVD and address the co
Autor:
Jane, Skov, Else-Marie, Bladbjerg, Morten A, Rasmussen, Johannes J, Sidelmann, Anja, Leppin, Jørgen, Jespersen
Publikováno v:
Basicclinical pharmacologytoxicology. 110(2)
Vitamin K antagonists (VKA) are highly effective anticoagulants but their use is hampered by multiple interactions with food and medicine and a narrow therapeutic range. The large variation in dose requirements has led to the development of several d
Autor:
Jonas A, Sjøland, Johannes J, Sidelmann, Mikkel, Brabrand, Robert S, Pedersen, Jørgen H, Pedersen, Kim, Esbensen, Kristina F, Standeven, Robert A S, Ariëns, Jørgen, Gram
Publikováno v:
Thrombosis and haemostasis. 98(2)
Fibrin clots with reduced permeability, increased clot stiffness and reduced fibrinolysis susceptibility may predispose to cardiovascular disease (CVD). Little is known, however, about the structure of fibrin clots in patients with end-stage renal di
Publikováno v:
Human Reproduction; Apr2007, Vol. 22 Issue 4, p1186-1186, 1p
Autor:
Gram J; Unit for Thrombosis Research, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark; Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark. Electronic address: joergen.gram@rsyd.dk., Skov J; Unit for Thrombosis Research, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark; Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark., Bladbjerg EM; Unit for Thrombosis Research, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark; Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark., Sidelmann J; Unit for Thrombosis Research, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark; Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark., Jespersen J; Unit for Thrombosis Research, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark; Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark.
Publikováno v:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2016 Feb; Vol. 25 (2), pp. 292-7. Date of Electronic Publication: 2015 Oct 28.
Autor:
Skov J; Unit for Thrombosis Research, Institute of Public Health, The University of Southern Denmark, c/o Department of Clinical Biochemistry, Hospital of South West Denmark, Finsensgade 35, DK-6700 Esbjerg, Denmark. jskov@health.sdu.dk, Bladbjerg EM, Sidelmann J, Vamosi M, Jespersen J
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2011 Nov; Vol. 67 (11), pp. 1169-74. Date of Electronic Publication: 2011 May 12.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2004 Jun 01; Vol. 169 (11), pp. 1258; author reply 1258-9.